ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Glucagon Injection Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-7U12635
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Glucagon Injection Market Research Report 2022
BUY CHAPTERS

Global Glucagon Injection Market Research Report 2025

Code: QYRE-Auto-7U12635
Report
February 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Amphastar Pharmaceuticals
Xeris Pharmaceuticals

Glucagon Injection Market Size

The global market for Glucagon Injection was valued at US$ 643 million in the year 2024 and is projected to reach a revised size of US$ 968 million by 2031, growing at a CAGR of 6.1% during the forecast period.

Glucagon Injection Market

Glucagon Injection Market

Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
The Glucagon injection market is driven by the rising prevalence of diabetes and hypoglycemia, and the growing awareness of the importance of emergency treatment for severe low blood sugar episodes. Glucagon injections are life-saving emergency medications used to rapidly raise blood sugar levels in individuals experiencing severe hypoglycemia. The rise in the global diabetic population and the need for effective management of insulin-related conditions contribute to market growth as glucagon injections offer a crucial solution in emergency situations. Moreover, advancements in device design and the development of user-friendly glucagon delivery systems have improved the accessibility and ease of administration. However, the market also faces challenges, including the need for patient education on proper administration and storage of glucagon injections, and the complexity of the regulatory landscape for medical emergency medications. Additionally, addressing affordability and expanding access to glucagon injections in various regions can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and reliable glucagon injection solutions, collaborate with healthcare providers to promote awareness and training, and address the challenges to meet the increasing demand for effective and life-saving emergency treatments for hypoglycemia.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Glucagon Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucagon Injection.
The Glucagon Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Glucagon Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glucagon Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Glucagon Injection Market Report

Report Metric Details
Report Name Glucagon Injection Market
Accounted market size in year US$ 643 million
Forecasted market size in 2031 US$ 968 million
CAGR 6.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Pharmacy
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Amphastar Pharmaceuticals, Xeris Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Glucagon Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Glucagon Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Glucagon Injection Market growing?

Ans: The Glucagon Injection Market witnessing a CAGR of 6.1% during the forecast period 2025-2031.

What is the Glucagon Injection Market size in 2031?

Ans: The Glucagon Injection Market size in 2031 will be US$ 968 million.

Who are the main players in the Glucagon Injection Market report?

Ans: The main players in the Glucagon Injection Market are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Amphastar Pharmaceuticals, Xeris Pharmaceuticals

What are the Application segmentation covered in the Glucagon Injection Market report?

Ans: The Applications covered in the Glucagon Injection Market report are Hospital, Pharmacy

What are the Type segmentation covered in the Glucagon Injection Market report?

Ans: The Types covered in the Glucagon Injection Market report are Vials, Prefilled

Recommended Reports

Diabetes Care Devices

Diabetes Therapeutics

Injection Therapies

1 Glucagon Injection Market Overview
1.1 Product Definition
1.2 Glucagon Injection by Type
1.2.1 Global Glucagon Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 Vials
1.2.3 Prefilled
1.3 Glucagon Injection by Application
1.3.1 Global Glucagon Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Glucagon Injection Market Size Estimates and Forecasts
1.4.1 Global Glucagon Injection Revenue 2020-2031
1.4.2 Global Glucagon Injection Sales 2020-2031
1.4.3 Global Glucagon Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Glucagon Injection Market Competition by Manufacturers
2.1 Global Glucagon Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Glucagon Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Glucagon Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Glucagon Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Glucagon Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glucagon Injection, Product Type & Application
2.7 Global Key Manufacturers of Glucagon Injection, Date of Enter into This Industry
2.8 Global Glucagon Injection Market Competitive Situation and Trends
2.8.1 Global Glucagon Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Glucagon Injection Players Market Share by Revenue
2.8.3 Global Glucagon Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Glucagon Injection Market Scenario by Region
3.1 Global Glucagon Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Glucagon Injection Sales by Region: 2020-2031
3.2.1 Global Glucagon Injection Sales by Region: 2020-2025
3.2.2 Global Glucagon Injection Sales by Region: 2026-2031
3.3 Global Glucagon Injection Revenue by Region: 2020-2031
3.3.1 Global Glucagon Injection Revenue by Region: 2020-2025
3.3.2 Global Glucagon Injection Revenue by Region: 2026-2031
3.4 North America Glucagon Injection Market Facts & Figures by Country
3.4.1 North America Glucagon Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Glucagon Injection Sales by Country (2020-2031)
3.4.3 North America Glucagon Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Glucagon Injection Market Facts & Figures by Country
3.5.1 Europe Glucagon Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Glucagon Injection Sales by Country (2020-2031)
3.5.3 Europe Glucagon Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glucagon Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Glucagon Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Glucagon Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Glucagon Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Glucagon Injection Market Facts & Figures by Country
3.7.1 Latin America Glucagon Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Glucagon Injection Sales by Country (2020-2031)
3.7.3 Latin America Glucagon Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Glucagon Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Glucagon Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Glucagon Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Glucagon Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Glucagon Injection Sales by Type (2020-2031)
4.1.1 Global Glucagon Injection Sales by Type (2020-2025)
4.1.2 Global Glucagon Injection Sales by Type (2026-2031)
4.1.3 Global Glucagon Injection Sales Market Share by Type (2020-2031)
4.2 Global Glucagon Injection Revenue by Type (2020-2031)
4.2.1 Global Glucagon Injection Revenue by Type (2020-2025)
4.2.2 Global Glucagon Injection Revenue by Type (2026-2031)
4.2.3 Global Glucagon Injection Revenue Market Share by Type (2020-2031)
4.3 Global Glucagon Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Glucagon Injection Sales by Application (2020-2031)
5.1.1 Global Glucagon Injection Sales by Application (2020-2025)
5.1.2 Global Glucagon Injection Sales by Application (2026-2031)
5.1.3 Global Glucagon Injection Sales Market Share by Application (2020-2031)
5.2 Global Glucagon Injection Revenue by Application (2020-2031)
5.2.1 Global Glucagon Injection Revenue by Application (2020-2025)
5.2.2 Global Glucagon Injection Revenue by Application (2026-2031)
5.2.3 Global Glucagon Injection Revenue Market Share by Application (2020-2031)
5.3 Global Glucagon Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Glucagon Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novo Nordisk Glucagon Injection Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Company Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Glucagon Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Eli Lilly Glucagon Injection Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Fresenius Kabi
6.3.1 Fresenius Kabi Company Information
6.3.2 Fresenius Kabi Description and Business Overview
6.3.3 Fresenius Kabi Glucagon Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Fresenius Kabi Glucagon Injection Product Portfolio
6.3.5 Fresenius Kabi Recent Developments/Updates
6.4 Torrent Labs
6.4.1 Torrent Labs Company Information
6.4.2 Torrent Labs Description and Business Overview
6.4.3 Torrent Labs Glucagon Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Torrent Labs Glucagon Injection Product Portfolio
6.4.5 Torrent Labs Recent Developments/Updates
6.5 Amphastar Pharmaceuticals
6.5.1 Amphastar Pharmaceuticals Company Information
6.5.2 Amphastar Pharmaceuticals Description and Business Overview
6.5.3 Amphastar Pharmaceuticals Glucagon Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Amphastar Pharmaceuticals Glucagon Injection Product Portfolio
6.5.5 Amphastar Pharmaceuticals Recent Developments/Updates
6.6 Xeris Pharmaceuticals
6.6.1 Xeris Pharmaceuticals Company Information
6.6.2 Xeris Pharmaceuticals Description and Business Overview
6.6.3 Xeris Pharmaceuticals Glucagon Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Xeris Pharmaceuticals Glucagon Injection Product Portfolio
6.6.5 Xeris Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glucagon Injection Industry Chain Analysis
7.2 Glucagon Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glucagon Injection Production Mode & Process Analysis
7.4 Glucagon Injection Sales and Marketing
7.4.1 Glucagon Injection Sales Channels
7.4.2 Glucagon Injection Distributors
7.5 Glucagon Injection Customer Analysis
8 Glucagon Injection Market Dynamics
8.1 Glucagon Injection Industry Trends
8.2 Glucagon Injection Market Drivers
8.3 Glucagon Injection Market Challenges
8.4 Glucagon Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Amphastar Pharmaceuticals
Xeris Pharmaceuticals
List of Tables
 Table 1. Global Glucagon Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Glucagon Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Glucagon Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Glucagon Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Glucagon Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Glucagon Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Glucagon Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Glucagon Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Glucagon Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Glucagon Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Glucagon Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Glucagon Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Glucagon Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucagon Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Glucagon Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Glucagon Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Glucagon Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Glucagon Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Glucagon Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Glucagon Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Glucagon Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Glucagon Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Glucagon Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Glucagon Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Glucagon Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Glucagon Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Glucagon Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Glucagon Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Glucagon Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Glucagon Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Glucagon Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Glucagon Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Glucagon Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Glucagon Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Glucagon Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Glucagon Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Glucagon Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Glucagon Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Glucagon Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Glucagon Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Glucagon Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Glucagon Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Glucagon Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Glucagon Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Glucagon Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Glucagon Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Glucagon Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Glucagon Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Glucagon Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Glucagon Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Glucagon Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Glucagon Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Glucagon Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Glucagon Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Glucagon Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Glucagon Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Glucagon Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Glucagon Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Glucagon Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Glucagon Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Glucagon Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Glucagon Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Glucagon Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Glucagon Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Glucagon Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Glucagon Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Glucagon Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Glucagon Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Novo Nordisk Company Information
 Table 71. Novo Nordisk Description and Business Overview
 Table 72. Novo Nordisk Glucagon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Novo Nordisk Glucagon Injection Product
 Table 74. Novo Nordisk Recent Developments/Updates
 Table 75. Eli Lilly Company Information
 Table 76. Eli Lilly Description and Business Overview
 Table 77. Eli Lilly Glucagon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Eli Lilly Glucagon Injection Product
 Table 79. Eli Lilly Recent Developments/Updates
 Table 80. Fresenius Kabi Company Information
 Table 81. Fresenius Kabi Description and Business Overview
 Table 82. Fresenius Kabi Glucagon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Fresenius Kabi Glucagon Injection Product
 Table 84. Fresenius Kabi Recent Developments/Updates
 Table 85. Torrent Labs Company Information
 Table 86. Torrent Labs Description and Business Overview
 Table 87. Torrent Labs Glucagon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Torrent Labs Glucagon Injection Product
 Table 89. Torrent Labs Recent Developments/Updates
 Table 90. Amphastar Pharmaceuticals Company Information
 Table 91. Amphastar Pharmaceuticals Description and Business Overview
 Table 92. Amphastar Pharmaceuticals Glucagon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Amphastar Pharmaceuticals Glucagon Injection Product
 Table 94. Amphastar Pharmaceuticals Recent Developments/Updates
 Table 95. Xeris Pharmaceuticals Company Information
 Table 96. Xeris Pharmaceuticals Description and Business Overview
 Table 97. Xeris Pharmaceuticals Glucagon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Xeris Pharmaceuticals Glucagon Injection Product
 Table 99. Xeris Pharmaceuticals Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Glucagon Injection Distributors List
 Table 103. Glucagon Injection Customers List
 Table 104. Glucagon Injection Market Trends
 Table 105. Glucagon Injection Market Drivers
 Table 106. Glucagon Injection Market Challenges
 Table 107. Glucagon Injection Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Glucagon Injection
 Figure 2. Global Glucagon Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Glucagon Injection Market Share by Type: 2024 & 2031
 Figure 4. Vials Product Picture
 Figure 5. Prefilled Product Picture
 Figure 6. Global Glucagon Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Glucagon Injection Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Pharmacy
 Figure 10. Global Glucagon Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Glucagon Injection Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Glucagon Injection Sales (2020-2031) & (K Units)
 Figure 13. Global Glucagon Injection Average Price (US$/Unit) & (2020-2031)
 Figure 14. Glucagon Injection Report Years Considered
 Figure 15. Glucagon Injection Sales Share by Manufacturers in 2024
 Figure 16. Global Glucagon Injection Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Glucagon Injection Players: Market Share by Revenue in Glucagon Injection in 2024
 Figure 18. Glucagon Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Glucagon Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Glucagon Injection Sales Market Share by Country (2020-2031)
 Figure 21. North America Glucagon Injection Revenue Market Share by Country (2020-2031)
 Figure 22. United States Glucagon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Glucagon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Glucagon Injection Sales Market Share by Country (2020-2031)
 Figure 25. Europe Glucagon Injection Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Glucagon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Glucagon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Glucagon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Glucagon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Glucagon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Glucagon Injection Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Glucagon Injection Revenue Market Share by Region (2020-2031)
 Figure 33. China Glucagon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Glucagon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Glucagon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Glucagon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Glucagon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Glucagon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Glucagon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Glucagon Injection Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Glucagon Injection Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Glucagon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Glucagon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Glucagon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Glucagon Injection Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Glucagon Injection Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Glucagon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Glucagon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Glucagon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Glucagon Injection by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Glucagon Injection by Type (2020-2031)
 Figure 52. Global Glucagon Injection Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Glucagon Injection by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Glucagon Injection by Application (2020-2031)
 Figure 55. Global Glucagon Injection Price (US$/Unit) by Application (2020-2031)
 Figure 56. Glucagon Injection Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Glucagon Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GLP 1 Injection Market Research Report 2024
GLP 1 for Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Insulin Biologics and Biosimilars Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hormonal Therapy for Type 2 Diabetes Market Research Report 2024
Global GLP 1 Weight Loss Drug Market Research Report 2024
Glucagon Injectable Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GLP 1 Agonist Injection Market Research Report 2024
Global GLP 1 Peptide Drugs Market Research Report 2024
Global Dulaglutide Market Research Report 2024
Global GLP 1 based Therapy Market Research Report 2024
Global Medication for Diabetes Market Research Report 2024
Global Mealtime Insulin Market Research Report 2024
Global GLP 1 Drug Peptide API Market Research Report 2024
Global Glucagon Market Research Report 2025
Global GLP 1 Weight Loss Injection Market Research Report 2024
Global Somatostatin for Injection Market Research Report 2024
Global Insulin Injection Equipment Market Research Report 2025
Global GLP 1RA Therapy Market Research Report 2024
Global Semaglutide Injection Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions